In a recent study, Hu’s team found that KRAS can upregulate CD47, an antiphagocytic signal exploited by tumor cells, through the PI3K/STAT3 pathway to evade innate immune surveillance [22]. The gene discussed is KRAS; the disease is neoplasm.